A Novel Eye Drop Candidate for Age-Related Macular Degeneration Treatment: Studies on its Pharmacokinetics and Distribution in Rats and Rabbits

Age-related macular degeneration (AMD) is wearing down of macula of retina, causing a blur or loss of vision in the center of the visual field. It can be categorized into dry or wet AMD. Until now, medical treatments for dry AMD have not been developed yet. The aim of this study was to evaluate phar...

Full description

Bibliographic Details
Main Authors: Eun-Jeong Choi, Go-Wun Choi, Ju Hee Kim, Hee-Woon Jang, Ju-Hee Lee, Hyun Ju Bae, Young Gwan Kim, Yong-Bok Lee, Hea-Young Cho
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/3/663
_version_ 1828785685096562688
author Eun-Jeong Choi
Go-Wun Choi
Ju Hee Kim
Hee-Woon Jang
Ju-Hee Lee
Hyun Ju Bae
Young Gwan Kim
Yong-Bok Lee
Hea-Young Cho
author_facet Eun-Jeong Choi
Go-Wun Choi
Ju Hee Kim
Hee-Woon Jang
Ju-Hee Lee
Hyun Ju Bae
Young Gwan Kim
Yong-Bok Lee
Hea-Young Cho
author_sort Eun-Jeong Choi
collection DOAJ
description Age-related macular degeneration (AMD) is wearing down of macula of retina, causing a blur or loss of vision in the center of the visual field. It can be categorized into dry or wet AMD. Until now, medical treatments for dry AMD have not been developed yet. The aim of this study was to evaluate pharmacokinetics (PKs) and tissue distribution of CK41016, a novel candidate for dry AMD, after intravenous (IV) or eye drop administration in rats and rabbits. In addition, a simple and sensitive bioanalytical method for CK41016 using ultra performance liquid chromatography-tandem mass spectrometer (UPLC-MS/MS) was developed. PK parameters were estimated by compartmental analysis using a WinNonlin<sup>&#174;</sup> software version 8.1 (a Certara&#8482; company). A PK model of CK41016 was well-described by the two-compartment model. The tissue-to-plasma partition coefficient (Kp) of CK41016 was the highest in the vitreous humor of rats and the cornea of rabbits after eye drop administration. In addition, the Caco-2 cell transporter assay confirmed that CK41016 was not an active substrate for the efflux transporter. In summary, the PKs and tissue distribution of CK41016 were successfully evaluated and investigated whether this drug was a substrate of efflux transporters.
first_indexed 2024-12-11T23:56:41Z
format Article
id doaj.art-485f937b03b8443cbf67b20a630fd79e
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-12-11T23:56:41Z
publishDate 2020-02-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-485f937b03b8443cbf67b20a630fd79e2022-12-22T00:45:20ZengMDPI AGMolecules1420-30492020-02-0125366310.3390/molecules25030663molecules25030663A Novel Eye Drop Candidate for Age-Related Macular Degeneration Treatment: Studies on its Pharmacokinetics and Distribution in Rats and RabbitsEun-Jeong Choi0Go-Wun Choi1Ju Hee Kim2Hee-Woon Jang3Ju-Hee Lee4Hyun Ju Bae5Young Gwan Kim6Yong-Bok Lee7Hea-Young Cho8College of Pharmacy, CHA University, 335 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 13488, KoreaCollege of Pharmacy, CHA University, 335 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 13488, KoreaCollege of Pharmacy, CHA University, 335 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 13488, KoreaCollege of Pharmacy, CHA University, 335 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 13488, KoreaKukje Pharma R&amp;D Center, Sanseong-ro 47, Ansan, Gyeonggi-do 15438, KoreaKukje Pharma R&amp;D Center, Sanseong-ro 47, Ansan, Gyeonggi-do 15438, KoreaKukje Pharma R&amp;D Center, Sanseong-ro 47, Ansan, Gyeonggi-do 15438, KoreaCollege of Pharmacy, Chonnam National University, 77 Yongbong-ro, Buk-Gu, Gwangju 61186, KoreaCollege of Pharmacy, CHA University, 335 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 13488, KoreaAge-related macular degeneration (AMD) is wearing down of macula of retina, causing a blur or loss of vision in the center of the visual field. It can be categorized into dry or wet AMD. Until now, medical treatments for dry AMD have not been developed yet. The aim of this study was to evaluate pharmacokinetics (PKs) and tissue distribution of CK41016, a novel candidate for dry AMD, after intravenous (IV) or eye drop administration in rats and rabbits. In addition, a simple and sensitive bioanalytical method for CK41016 using ultra performance liquid chromatography-tandem mass spectrometer (UPLC-MS/MS) was developed. PK parameters were estimated by compartmental analysis using a WinNonlin<sup>&#174;</sup> software version 8.1 (a Certara&#8482; company). A PK model of CK41016 was well-described by the two-compartment model. The tissue-to-plasma partition coefficient (Kp) of CK41016 was the highest in the vitreous humor of rats and the cornea of rabbits after eye drop administration. In addition, the Caco-2 cell transporter assay confirmed that CK41016 was not an active substrate for the efflux transporter. In summary, the PKs and tissue distribution of CK41016 were successfully evaluated and investigated whether this drug was a substrate of efflux transporters.https://www.mdpi.com/1420-3049/25/3/663ck41016dry age-related macular generationpharmacokineticstissue distributioncaco-2
spellingShingle Eun-Jeong Choi
Go-Wun Choi
Ju Hee Kim
Hee-Woon Jang
Ju-Hee Lee
Hyun Ju Bae
Young Gwan Kim
Yong-Bok Lee
Hea-Young Cho
A Novel Eye Drop Candidate for Age-Related Macular Degeneration Treatment: Studies on its Pharmacokinetics and Distribution in Rats and Rabbits
Molecules
ck41016
dry age-related macular generation
pharmacokinetics
tissue distribution
caco-2
title A Novel Eye Drop Candidate for Age-Related Macular Degeneration Treatment: Studies on its Pharmacokinetics and Distribution in Rats and Rabbits
title_full A Novel Eye Drop Candidate for Age-Related Macular Degeneration Treatment: Studies on its Pharmacokinetics and Distribution in Rats and Rabbits
title_fullStr A Novel Eye Drop Candidate for Age-Related Macular Degeneration Treatment: Studies on its Pharmacokinetics and Distribution in Rats and Rabbits
title_full_unstemmed A Novel Eye Drop Candidate for Age-Related Macular Degeneration Treatment: Studies on its Pharmacokinetics and Distribution in Rats and Rabbits
title_short A Novel Eye Drop Candidate for Age-Related Macular Degeneration Treatment: Studies on its Pharmacokinetics and Distribution in Rats and Rabbits
title_sort novel eye drop candidate for age related macular degeneration treatment studies on its pharmacokinetics and distribution in rats and rabbits
topic ck41016
dry age-related macular generation
pharmacokinetics
tissue distribution
caco-2
url https://www.mdpi.com/1420-3049/25/3/663
work_keys_str_mv AT eunjeongchoi anoveleyedropcandidateforagerelatedmaculardegenerationtreatmentstudiesonitspharmacokineticsanddistributioninratsandrabbits
AT gowunchoi anoveleyedropcandidateforagerelatedmaculardegenerationtreatmentstudiesonitspharmacokineticsanddistributioninratsandrabbits
AT juheekim anoveleyedropcandidateforagerelatedmaculardegenerationtreatmentstudiesonitspharmacokineticsanddistributioninratsandrabbits
AT heewoonjang anoveleyedropcandidateforagerelatedmaculardegenerationtreatmentstudiesonitspharmacokineticsanddistributioninratsandrabbits
AT juheelee anoveleyedropcandidateforagerelatedmaculardegenerationtreatmentstudiesonitspharmacokineticsanddistributioninratsandrabbits
AT hyunjubae anoveleyedropcandidateforagerelatedmaculardegenerationtreatmentstudiesonitspharmacokineticsanddistributioninratsandrabbits
AT younggwankim anoveleyedropcandidateforagerelatedmaculardegenerationtreatmentstudiesonitspharmacokineticsanddistributioninratsandrabbits
AT yongboklee anoveleyedropcandidateforagerelatedmaculardegenerationtreatmentstudiesonitspharmacokineticsanddistributioninratsandrabbits
AT heayoungcho anoveleyedropcandidateforagerelatedmaculardegenerationtreatmentstudiesonitspharmacokineticsanddistributioninratsandrabbits
AT eunjeongchoi noveleyedropcandidateforagerelatedmaculardegenerationtreatmentstudiesonitspharmacokineticsanddistributioninratsandrabbits
AT gowunchoi noveleyedropcandidateforagerelatedmaculardegenerationtreatmentstudiesonitspharmacokineticsanddistributioninratsandrabbits
AT juheekim noveleyedropcandidateforagerelatedmaculardegenerationtreatmentstudiesonitspharmacokineticsanddistributioninratsandrabbits
AT heewoonjang noveleyedropcandidateforagerelatedmaculardegenerationtreatmentstudiesonitspharmacokineticsanddistributioninratsandrabbits
AT juheelee noveleyedropcandidateforagerelatedmaculardegenerationtreatmentstudiesonitspharmacokineticsanddistributioninratsandrabbits
AT hyunjubae noveleyedropcandidateforagerelatedmaculardegenerationtreatmentstudiesonitspharmacokineticsanddistributioninratsandrabbits
AT younggwankim noveleyedropcandidateforagerelatedmaculardegenerationtreatmentstudiesonitspharmacokineticsanddistributioninratsandrabbits
AT yongboklee noveleyedropcandidateforagerelatedmaculardegenerationtreatmentstudiesonitspharmacokineticsanddistributioninratsandrabbits
AT heayoungcho noveleyedropcandidateforagerelatedmaculardegenerationtreatmentstudiesonitspharmacokineticsanddistributioninratsandrabbits